GGrantIndex
Sort

326,823 grants matching clinical trial

Texas EXperimental Cancer Therapeutics Network - TEX CTN

$1,679,285
Funda Meric-Bernstam · University Of Tx Md Anderson Can Ctr · UM1 · FY2025 · CA

Texas EXperimental Cancer Therapeutics Network - TEX CTN

$1,679,285
Funda Meric-Bernstam · University Of Tx Md Anderson Can Ctr · UM1 · FY2024 · CA

Biological And Biochemical Characterization Of Sigma Receptors

$1,679,280
Tsung-Ping Ping Su · National Institute On Drug Abuse · ZIA · FY2023 · DA

Peruvian/Brazilian Amazon Center of Excellence in Malaria

$1,678,997
Joseph M. Vinetz · University Of California, San Diego · U19 · FY2014 · AI

Structure and Function of Beta3 Integrins

$1,678,976
Edward Franklin Plow · Cleveland Clinic Lerner Com-Cwru · P01 · FY2015 · HL

Structure and Function of Beta3 Integrins

$1,678,976
Edward Franklin Plow · Cleveland Clinic Lerner Com-Cwru · P01 · FY2019 · HL

Structure and Function of Beta3 Integrins

$1,678,970
Edward Franklin Plow · Cleveland Clinic Lerner Com-Cwru · P01 · FY2016 · HL

Structure and Function of Beta3 Integrins

$1,678,970
Edward Franklin Plow · Cleveland Clinic Lerner Com-Cwru · P01 · FY2017 · HL

UNMC Eppley Cancer Center Support Grant

$1,678,886
Kenneth Cowan · University Of Nebraska Medical Center · P30 · FY2009 · CA

ADULT AIDS CLINICAL TRIALS UNIT (ACTU)

$1,678,880
University Of Southern California · U01 · FY2005 · AI

OPTIMIZE - CCC - Lead Application

$1,678,874
Bonnie W Ramsey · Seattle Children'S Hospital · U01 · FY2014 · HL

Lifespan/Tufts/brown Center for AIDS Research (CFAR)

$1,678,852
Susan Cu-Uvin · Miriam Hospital · P30 · FY2016 · AI

Clinical evaluation of BMS-984923 metabolism.

$1,678,603
Timothy R Siegert · Allyx Therapeutics Inc. · SB1 · FY2024 · AG

Consequences of Prolonged Febrile Seizures in Childhood

$1,678,590
Shlomo Shinnar · Albert Einstein College Of Medicine · R37 · FY2019 · NS

Preclinical Studies of Vaccines for Pandemic Influenza

$1,678,567
Kanta Subbarao · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI

Core C Imaging

$1,678,559
Michael I Miller · Johns Hopkins University · U19 · FY2020 · AG

Effects of mu-opiate receptor engagement on microbial translocation and residual immune activation in HIV-infected, ART suppressed opioid use disorder patents initiating medication-assisted treatment

$1,678,538
Luis J. Montaner · Wistar Institute · R01 · FY2021 · DA

Stellenbosch University Clinical Trial Unit, Cape Town, South Africa

$1,678,426
Mark Fredric Cotton · Stellenbosch University · U01 · FY2007 · AI

UCLA SPOTRIAS Center Application

$1,678,318
Jeffrey L Saver · University Of California Los Angeles · P50 · FY2007 · NS

Hormonal, Metabolic and Signaling Interactions in PAH

$1,678,313
Anna R Hemnes · Vanderbilt University Medical Center · P01 · FY2021 · HL

Immunologic control of HIV-1 through combination bNAbs and biologics.

$1,678,283
Marina Caskey · Rockefeller University · U01 · FY2019 · AI

Cancer and Leukemia Group B

$1,678,199
University Of Chicago · U10 · FY2005 · CA

An INteractive Survivorship Program to Improve Healthcare REsources [INSPIRE] for Adolescent and Young Adult (AYA) Cancer Survivors

$1,678,022
Kevin S Baker · Fred Hutchinson Cancer Research Center · U01 · FY2020 · CA

NIH PROMIS Statistical Coordinating Center(RMI)

$1,677,760
David Cella · Northshore University Healthsystem · U01 · FY2007 · AR

Core-004

$1,677,713
Gloria David · Rho Federal Systems Division, Inc. · UM2 · FY2022 · AI